Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Brentuximab may cause hair to regain color.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Ruxolitinib can help regrow hair in severe alopecia areata.

Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.

PBMCsec can help reduce and improve thick skin scars.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Abrocitinib may effectively treat stubborn alopecia universalis.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Baricitinib is effective and safe for treating severe alopecia areata.

Rebamipide may help regrow hair by activating hair follicle stem cells.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.